Skip to content

Observation of long term malignant change of oral leukoplakia treated by ALA photodynamic therapy

Observation of long term malignant change of oral leukoplakia treated by ALA photodynamic therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080301
Enrollment
Unknown
Registered
2024-01-25
Start date
2024-01-25
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral leukoplakia

Interventions

Study group (Retrospective cohort):received ALA photodynamic therapy for 5 years
Study Group (Prospective Cohort):received photodynamic therapy for less than 5 years

Sponsors

Peking University School of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with vitiligo by clinical and pathological conditions. (2) Have a complete medical history and be able to follow up for 5 years.

Exclusion criteria

Exclusion criteria: (1) no pathological diagnosis (2) medical history less than 5 years or lost to follow-up; Incomplete medical records (3) Cases of mismatch between gender, age, and pathological classification between the control group and the exposed group were eliminated. (4) Patients in a prospective cohort study who are unwilling to join this study for any reason

Design outcomes

Primary

MeasureTime frame
time of malignant transformation;

Secondary

MeasureTime frame
duration of leukoplakia;time of pathological diagnosis;treatment;smoking;drinking;chew betel nut;Non-invasive test results;time of photodynamic therapy;time of again pathological time;

Countries

China

Contacts

Public ContactYing Han

Peking University School of Stomatology

13683375487@163.com+86 136 8337 5487

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026